DK2379114T3 - Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser - Google Patents

Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser

Info

Publication number
DK2379114T3
DK2379114T3 DK09768395.7T DK09768395T DK2379114T3 DK 2379114 T3 DK2379114 T3 DK 2379114T3 DK 09768395 T DK09768395 T DK 09768395T DK 2379114 T3 DK2379114 T3 DK 2379114T3
Authority
DK
Denmark
Prior art keywords
conjugates
containing compounds
nanoparticles coated
platinum containing
platinum
Prior art date
Application number
DK09768395.7T
Other languages
English (en)
Inventor
Puntes Víctor Franco
Puente Fernando Domínguez
Martínez Francisco Manuel Romero
Rubio Óscar Gallego
Original Assignee
Univ Santiago Compostela
Fundació Privada Inst Catal De Nanotecnologia
Institució Catalana De Recerca I Estudis Avançats
Univ Valencia
Fundació Privada Inst De Recerca De L Hospital De La Santa Creu I Sant Pau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Compostela, Fundació Privada Inst Catal De Nanotecnologia, Institució Catalana De Recerca I Estudis Avançats, Univ Valencia, Fundació Privada Inst De Recerca De L Hospital De La Santa Creu I Sant Pau filed Critical Univ Santiago Compostela
Application granted granted Critical
Publication of DK2379114T3 publication Critical patent/DK2379114T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Powder Metallurgy (AREA)
DK09768395.7T 2008-12-16 2009-12-15 Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser DK2379114T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08171870 2008-12-16
PCT/EP2009/067136 WO2010069941A1 (en) 2008-12-16 2009-12-15 Conjugates comprising nanoparticles coated with platinum containing compounds

Publications (1)

Publication Number Publication Date
DK2379114T3 true DK2379114T3 (da) 2014-09-29

Family

ID=40568646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09768395.7T DK2379114T3 (da) 2008-12-16 2009-12-15 Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser

Country Status (13)

Country Link
US (1) US9023370B2 (da)
EP (1) EP2379114B1 (da)
JP (1) JP5873719B2 (da)
CA (1) CA2745972C (da)
CY (1) CY1115601T1 (da)
DK (1) DK2379114T3 (da)
ES (1) ES2505890T3 (da)
HR (1) HRP20140804T1 (da)
IL (1) IL213408A (da)
PL (1) PL2379114T3 (da)
PT (1) PT2379114E (da)
SI (1) SI2379114T1 (da)
WO (1) WO2010069941A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909435D0 (en) * 2009-06-02 2009-07-15 Univ Strathclyde Nanoparticle for biomolecule delivery
ES2392528B1 (es) * 2010-12-28 2013-10-21 Endor Nanotechnologies, S.L. Sistema de liberación de agente terapéutico, composiciones farmacéuticas que lo contienen, su preparación y su uso médico.
ITRM20130138A1 (it) 2013-03-07 2014-09-08 Consiglio Nazionale Ricerche Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
JP6316011B2 (ja) * 2014-02-04 2018-04-25 国立大学法人滋賀医科大学 抗癌剤が担持されたナノ粒子
US11007276B2 (en) * 2016-01-29 2021-05-18 National University Corporation Hokkaido University Intracellular substance transport system and use thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
ES2924863T3 (es) 2019-01-08 2022-10-11 Nanonica S A Conjugados que comprenden nanopartículas recubiertas con derivados de platino a través de enlazadores que contienen sulfonilo o fosfonilo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851932B (da) 1984-08-14 1985-12-13 Engelhard Corp
JP2866554B2 (ja) 1992-08-25 1999-03-08 松下電器産業株式会社 情報記録媒体とその製造方法及び情報記録媒体の使用方法
EP1531868A2 (en) 2002-06-03 2005-05-25 Alnis Biosciences, Inc. Therapeutic agent-containing polymeric nanoarticles
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
US8785505B2 (en) * 2005-10-28 2014-07-22 The Regents Of The University Of California Toxicology and cellular effect of manufactured nanomaterials

Also Published As

Publication number Publication date
CA2745972A1 (en) 2010-06-24
EP2379114A1 (en) 2011-10-26
CA2745972C (en) 2016-11-01
JP2012512149A (ja) 2012-05-31
PL2379114T3 (pl) 2014-12-31
PT2379114E (pt) 2014-10-06
HRP20140804T1 (hr) 2014-11-07
US9023370B2 (en) 2015-05-05
ES2505890T3 (es) 2014-10-10
IL213408A (en) 2017-06-29
SI2379114T1 (sl) 2014-11-28
EP2379114B1 (en) 2014-07-09
WO2010069941A1 (en) 2010-06-24
CY1115601T1 (el) 2017-01-04
JP5873719B2 (ja) 2016-03-01
US20110262500A1 (en) 2011-10-27
IL213408A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
BRPI0911067A2 (pt) imunoensaios sensíveis usando nanopartículas revestidas
BRPI0910515A2 (pt) composição líquida
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0914254A2 (pt) compostos anti-infectivos
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0921629A2 (pt) composição de revestimento anti-incrustação compreendendo nanopartículas
BRPI0908269A2 (pt) aplicador
BRPI0917231A2 (pt) composição
BRPI0918823A2 (pt) beta-glicosidases modificadas com estabilidades aperfeicoada
DK2275414T3 (da) Cyclopentylacrylamidderivat
BRPI0917186A2 (pt) partículas sólidas revestidas
ATE510152T1 (de) Verbesserte differenzialhalteringanordnung
DK2252471T3 (da) Blyant
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
DK2379114T3 (da) Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser
BRPI0914098A2 (pt) biosensor
DK2323933T3 (da) Stableenhed
DK2277578T3 (da) Forstøver
BRPI0922256A2 (pt) composições de nanopartículas
BRPI0917584A2 (pt) composição
BRPI0920692A2 (pt) composição
DK2119364T3 (da) Piskbar sammensætning
FI20080325A (fi) Pihkaliuos
BRPI0919801A2 (pt) revestimento ii